MedTrace Logo

Neuroretinal Biomarkers in Neurodegenerative Diseases

NCT02047760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2016-05-11

No results posted yet for this study

Summary

There is increasing evidence that examining our eyes can tell us a lot of information about our health, and systemic diseases. We want to study what eyes can reveal about serious neurodegenerative diseases like multiple sclerosis, and motor neurone disease, by analysing the retinal images from a simple non-invasive eye scan, that is already being routinely used to provide immediate clinical information in this group of patients.

Conditions

Sponsors & Collaborators

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • James Cameron, FRCOphth · University of Edinburgh

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02047760 on ClinicalTrials.gov